Geoffrey M. Parker Perrigo CO PLC (PRGO) insider trading activity

Geoffrey M. Parker is Director of PERRIGO Co plc. Currently has a direct ownership of 28,912 shares of PRGO, which is worth approximately $773,974. The most recent transaction as insider was on May 14, 2025, when has been sold 4,754 shares (Ordinary Shares) at a price of $26.01 per share, resulting in proceeds of $123,651. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.9K

42.69% 3M change

42.69% 12M change

Total Value Held $773,974

Geoffrey M. Parker Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 14 2025	SELL Payment of exercise price or tax liability	$123,651 $26.01 p/Share	4,754 Reduced 14.12%	28,912 Ordinary Shares
May 14 2025	BUY Exercise of conversion of derivative security	$257,603 $26.01 p/Share	9,904 Added 22.73%	33,666 Ordinary Shares
May 12 2025	BUY Open market or private purchase	$94,850 $27.1 p/Share	3,500 Added 12.84%	23,762 Ordinary Shares
May 15 2024	SELL Payment of exercise price or tax liability	$127,135 $30.22 p/Share	4,207 Reduced 17.19%	20,262 Ordinary Shares
May 15 2024	BUY Exercise of conversion of derivative security	$264,848 $30.22 p/Share	8,764 Added 26.37%	24,469 Ordinary Shares
May 17 2023	SELL Payment of exercise price or tax liability	$122,699 $32.86 p/Share	3,734 Reduced 19.21%	15,705 Ordinary Shares
May 17 2023	BUY Exercise of conversion of derivative security	$255,585 $32.86 p/Share	7,778 Added 28.58%	19,439 Ordinary Shares
May 17 2022	SELL Payment of exercise price or tax liability	$122,190 $38.57 p/Share	3,168 Reduced 21.36%	11,661 Ordinary Shares
May 17 2022	BUY Exercise of conversion of derivative security	$254,523 $38.57 p/Share	6,599 Added 30.8%	14,829 Ordinary Shares
May 07 2021	SELL Payment of exercise price or tax liability	$119,687 $42.96 p/Share	2,786 Reduced 19.56%	11,459 Ordinary Shares
May 07 2021	BUY Exercise of conversion of derivative security	$249,340 $42.96 p/Share	5,804 Added 28.95%	14,245 Ordinary Shares

Also insider at

TCDA

Tricida, Inc. Healthcare

COO, CFO and EVP

CCXI

ChemoCentryx, Inc.

Director

BTTX

Better Therapeutics, Inc. Healthcare

ALLO

Allogene Therapeutics, Inc. Healthcare

CHIEF FINANCIAL OFFICER

GMP